Tnfrsf9^em1Ygch

Zinc finger nuclease technology was used to target exon 4. Founder line 6 contains a 2 bp deletion (CTCCAG to CTAG) that introduces a premature stop codon. Flow cytometry confirmed the absence of protein expression on T cells. (J:208927)